OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BCLXL gene therapy moderates neuropathology in the DBA/2J mouse model of inherited glaucoma
Ryan Donahue, Rachel L. Fehrman, Jenna R. Gustafson, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 8
Open Access | Times Cited: 44

Showing 26-50 of 44 citing articles:

New strategies for neuro protection in glaucoma
Xuejiao Yang, Yan Junwei
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 5

Stem cells and genetic engineering empower therapeutic development for blinding eye diseases
Chang-Jun Zhang, Kangxin Jin, Zi‐Bing Jin
Elsevier eBooks (2023), pp. 139-170
Closed Access | Times Cited: 2

Gene therapies and gene product-based drug candidates for normalizing and preserving tissue functions in animal models of ocular hypertension and glaucoma
Najam A. Sharif
Molecular Aspects of Medicine (2023) Vol. 94, pp. 101218-101218
Closed Access | Times Cited: 2

BclXL (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
Olivia J. Marola, Sarah E. R. Yablonski, Peter Shrager, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 3

Gene Therapy for Neurodegeneration in Glaucoma
Jamie J. Karl, Henry Tseng
Essentials in ophthalmology/Essentials ophthalmology (2024), pp. 337-354
Closed Access

Eye Disease Genetics and Therapeutics
Najam A. Sharif, Nozhat Choudry, Saima D. Chaudhry, et al.
Essentials in ophthalmology/Essentials ophthalmology (2024), pp. 225-255
Closed Access

TLR4 deficiency does not alter glaucomatous progression in a mouse model of chronic glaucoma
Chi Zhang, Marina Simón, Jeffrey M. Harder, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

MKK4 and MKK7 control degeneration of retinal ganglion cell somas and axons after glaucoma-relevant injury.
Olivia J. Marola, Stephanie B. Syc‐Mazurek, Sarah E. R. Yablonski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Glaucoma pathology
Gregg Heatley, Robert W. Nickells
Elsevier eBooks (2023), pp. 3-15
Closed Access | Times Cited: 1

Emerging Gene Therapy Technologies for Retinal Ganglion Cell Neuroprotection
David K. Camacho, Cammille C. Go, Brahim Chaqour, et al.
Journal of Neuro-Ophthalmology (2023)
Closed Access | Times Cited: 1

Cytokine polarized, alternatively activated bone marrow neutrophils drive axon regeneration
Benjamin M. Segal, Andrew Jerome, Andrew Sas, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1

Glaucoma - Recent Advances and New Perspectives

IntechOpen eBooks (2022)
Open Access | Times Cited: 1

Gene therapy for ocular hypertension and glaucoma treatment
Najam A. Sharif
Elsevier eBooks (2022), pp. 309-316
Closed Access | Times Cited: 1

Perspective on Gene Therapy for Glaucoma
Mariana Santana Dias, Victor G. Araújo, Rafael Lani‐Louzada, et al.
IntechOpen eBooks (2022)
Open Access | Times Cited: 1

BAX activation in mouse retinal ganglion cells occurs in two temporally and mechanistically distinct steps
Margaret E. Maes, Ryan Donahue, Cassandra L. Schlamp, et al.
Research Square (Research Square) (2023)
Open Access

High density aromatic peptides protect retinal ganglion cells in mouse retina following optic nerve crush injury
Margaret A. MacNeil, Virginia García‐Marín, Alexander Birk
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Previous Page - Page 2

Scroll to top